首页> 外文期刊>The Lancet >Compression stockings to prevent post-thrombotic syndrome: A randomised placebo-controlled trial
【24h】

Compression stockings to prevent post-thrombotic syndrome: A randomised placebo-controlled trial

机译:加压袜预防血栓形成后综合征:一项随机安慰剂对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background Post-thrombotic syndrome (PTS) is a common and burdensome complication of deep venous thrombosis (DVT). Previous trials suggesting benefit of elastic compression stockings (ECS) to prevent PTS were small, singlecentre studies without placebo control. We aimed to assess the efficacy of ECS, compared with placebo stockings, for the prevention of PTS. Methods We did a multicentre randomised placebo-controlled trial of active versus placebo ECS used for 2 years to prevent PTS after a first proximal DVT in centres in Canada and the USA. Patients were randomly assigned to study groups with a web-based randomisation system. Patients presenting with a first symptomatic, proximal DVT were potentially eligible to participate. They were excluded if the use of compression stockings was contraindicated, they had an expected lifespan of less than 6 months, geographical inaccessibility precluded return for follow-up visits, they were unable to apply stockings, or they received thrombolytic therapy for the initial treatment of acute DVT. The primary outcome was PTS diagnosed at 6 months or later using Ginsbergs criteria (leg pain and swelling of ≥1 month duration). We used a modified intention to treat Cox regression analysis, supplemented by a prespecified per-protocol analysis of patients who reported frequent use of their allocated treatment. This study is registered with ClinicalTrials. gov, number NCT00143598, and Current Controlled Trials, number ISRCTN71334751. Findings From 2004 to 2010, 410 patients were randomly assigned to receive active ECS and 396 placebo ECS. The cumulative incidence of PTS was 14·2% in active ECS versus 12·7% in placebo ECS (hazard ratio adjusted for centre 1·13, 95% CI 0·73-1·76; p=0·58). Results were similar in a prespecified per-protocol analysis of patients who reported frequent use of stockings. Interpretation ECS did not prevent PTS after a first proximal DVT, hence our findings do not support routine wearing of ECS after DVT.
机译:背景血栓后综合症(PTS)是深静脉血栓形成(DVT)的常见且繁重的并发症。先前的试验表明,弹性加压袜(ECS)预防PTS的益处是一项小型,单中心研究,无安慰剂对照。我们旨在评估与安慰剂相比,ECS预防PTS的功效。方法我们在加拿大和美国的中心首次进行近端DVT治疗后,进行了两年主动性安慰剂与安慰剂ECS预防PTS的多中心随机安慰剂对照试验。使用基于网络的随机系统将患者随机分配至研究组。首次出现症状性近端DVT的患者可能有资格参加。如果禁忌使用压力袜,预期寿命少于6个月,由于无法进入地理区域而无法再随访,或者无法使用袜,或者接受溶栓治疗以初步治疗,则将他们排除在外。急性DVT。主要结果是使用Ginsbergs标准在6个月或更晚时诊断为PTS(腿痛和肿胀≥1个月)。我们使用修改后的意图来治疗Cox回归分析,并辅以对报告频繁使用分配的治疗方法的患者进行预先确定的按方案分析。该研究已在ClinicalTrials中注册。 gov,编号NCT00143598,以及“电流对照试验”,编号ISRCTN71334751。研究结果从2004年到2010年,有410名患者被随机分配接受主动ECS和396名安慰剂ECS。活动性ECS中PTS的累积发生率为14·2%,而安慰剂ECS中为12·7%(针对中心1·13调整的危险比,95%CI 0·73-1·76; p = 0·58)。在对预先报告的频繁使用丝袜的患者进行的预先协议分析中,结果相似。解释ECS不能在首次近端DVT后预防PTS,因此我们的发现不支持DVT后常规佩戴ECS。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号